Merge Healthcare (NASDAQ:MRGE)(TSX:MRG), a leading medical imaging solutions provider, announced the launch of a dedicated MergeCOM–3 TM web site, providing on–line resources and community for Digital Imaging and Communications in Medicine ("DICOM") developers.
The new web site, www.mergecom3.com, offers evaluation downloads for the latest version of MergeCOM–3 TM, development resources and training course information. The latest version of MergeCOM–3 TM (Release 3.8) download is available for both Windows and Linux operating systems, supporting programming in C/C++, C#.Net and Java programming languages. Documentation available includes, programming manuals, code samples and key release information for version 3.8. MergeCOM–3 TM. Release 3.8 introduces support for a number of key DICOM standard supplements, as well as improved multi–threading capability, compression support and updated sample applications.
"DICOM expertise and MergeCOM–3 TM are a core part of Merge´s history and a cornerstone for our future growth", said Justin Dearborn, CEO of Merge Healthcare, "I am excited about the launch of our new dedicated MergeCOM–3 TM web site which provides real time access to valuable developer resources and information as well as trial downloads of our latest products."
MergeCOM–3 TM is an industry leading DICOM interface toolkit, widely used in medical imaging devices and systems. MergeCOM–3 TM is available for a wide variety of operating systems and programming platforms, including Microsoft Windows XP, Microsoft Windows
Vista, Linux and Unix operating systems; C/C++, C#/.Net and Java programming platforms; supporting both 32 and 64 bit run–time environments. As a member of the DICOM Standards Committee, it is our policy to incorporate all significant changes to the DICOM standard within 3 months of adoption by the Committee.
Microsoft Windows and .Net are registered trademarks or trademarks of Microsoft Corporation. Java is trademark of Sun Microsystems, Inc.
Merge Healthcare is a leading medical imaging software and services company. Our innovative software solutions use leading–edge imaging software technologies that accelerate market delivery for our OEM customers, while our end–user solutions improve our customers´ productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Merge Healthcare.
Except for the historical information herein, the matters discussed in this news release include forward–looking statements that may involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward–looking statements. Actual results could differ materially from those expressed in, or implied by, the forward–looking statements based on a number of factors, including, but not limited to, market acceptance and performance of the Company´s products and services, including the Company´s teleradiology product and services; delay in the offering of the Company´s teleradiology product and services; the Company´s ability to attract and retain qualified radiologist consultants; risks and effects of the past restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company´s ability to generate sufficient cash from operations to meet future operating, financing and capital requirements; risks associated with the Company´s failing to make timely filings with the SEC or its inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the formal investigation being conducted by the Securities and Exchange Commission and class action and derivative lawsuits; the impact of competitive products and pricing; and other risk factors detailed in the Company´s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward–looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
